5% PROMISSORY NOTEConvertible Security Agreement • September 24th, 2021 • Regen BioPharma Inc • Pharmaceutical preparations • New York
THIS IS A 5% PROMISSORY NOTE of Regen Biopharma, Inc., a Nevada corporation (the “Company”), having its principal place of business at 711 S. Carson Street, Suite 4, Carson City, Nevada 89791 (this “Note”), which represents a duly authorized and validly issued debt of the Company.
SETTLEMENT AND RELEASE AGREEMENTSettlement Agreement • September 24th, 2021 • Regen BioPharma Inc • Pharmaceutical preparations • California
This Settlement and Release Agreement (the "Agreement") is entered into by and between CHEMDIV, INC. ("Chemdiv"), REGEN BIOPHARMA, INC. ("Regen"), ZANDER THERAPEUTICS, INC., and DAVID KOOS ("Koos"). Regen, Zander, and Koos may sometimes be collectively referred to herein as "Defendants." Chemdiv and Defendants are sometimes collectively referred to herein as the "Parties."
